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The seminal discovery of Herbst and his coworkers
(1971,1986) that early in utero exposure to diethylstilboestrol
(DES) is associated with adolescent and young adult adeno-
carcinoma of the vagina in female offspring led us to suggest
a related mechanism for the development of germ cell
tumours of the testis (Henderson et al., 1983). These testis
tumours occur most frequently in young adult males and the
age-specific incidence curve shows a broad peak between 20
and 39 years of age (Ross et al., 1979; Newell et al., 1984).
Several studies have examined the risk of testis cancer
associated with in utero exposure to exogenous oestrogens.
Two of these found few subjects with such exposures. In one
there was no evidence of an increased risk (Brown et al.,
1986) and in the other there was a positive, but not
statistically significant, association with DES only (Moss
et al., 1986). We and others observed a strong positive
association between in utero exposure in early pregnancy to
DES or other oestrogenic substances and risk of testis cancer
in the offspring (Henderson et al., 1979; Schottenfeld et al.,
1980; Depue et al., 1983). Based on these positive findings,
we formulated an hypothesis which stated that, in such
cases, the risk of germ cell tumours of the testis was
determined in utero by the abrupt change in oestrogen levels
resulting from the administration of exogenous oestrogens
which interrupted the progression of primitive germ cells to
mature germ cells (Henderson et al., 1982,1983). These
primitive germ cells, persisting into the pubertal period,
would multiply under stimulation by gonadotrophins and
give rise to germ cell tumours of a variety of histological
types depending on their particular stage of 'developmental
arrest'.
Some support for this hypothesis can be found in the
experimental literature. Yasuda et al. (1985a) have reported
the persistence of gonadocytes following in utero adminis-
tration of oestrogen to mice. Testicular anomalies and
testicular maldescent (i.e., cryptorchidism, a major risk
factor for testis cancer) can be produced by the adminis-
tration of DES to mice and rats (Burns, 1955; McLachlin et
al., 1975; Walker, 1980; Yasuda et al., 1985b).
In further analyses of our two case-control studies of testis
cancer, we also observed risk to be associated with maternal
obesity prior to, and hyperemesis during, the index
pregnancy (Henderson et al., 1979; Depue et al., 1983).
Obesity may reflect higher endogenous oestrogen levels as it
has been found to be associated with increased levels of
oestradiol (E2) in post-menopausal women, particularly the
'free' or non-protein bound fractions, which may be due, in
part, to the related decreased levels of sex hormone binding
globulin (Nisker et al., 1980). Although nausea and vomiting
of pregnancy have been ascribed by some to the high and
rising human chorionic gonadotrophin (hCG) levels of the
first trimester (Kauppila et al., 1979), others have been
unable to relate these conditions to higher hCG (Soules et
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al., 1980). We recently reported that hyperemesis may be
similarly associated with excess levels of free E2 during the
initial weeks of pregnancy (Depue et al., 1987). These two
observations have led us to speculate further that the level of
free E2 in maternal blood at the time of differentiation of
the primitive germ cell could have the same effect as
exogenously administered oestrogens, viz. to delay or
interrupt normal germ cell maturation (Henderson et al.,
1983).
Another important descriptive feature of the disease, the
rarity of testis cancer in black males (Ross et al., 1979;
Newell et al., 1983), also appears compatible with this
'oestrogen excess' hypothesis. During the past several
decades, while the incidence of testis cancer has been
increasing in white males, the rates in black males have
remained stable and are considerably lower. In searching for
an explanation for this 'protection' afforded black males, we
studied the hormone levels in maternal blood of black and
white women during early pregnancy. These women
participated in the Collaborative Perinatal Project of the
National Institute of Neurological and Communicative
Disorders and Stroke (Niswander & Gordon, 1972). In this
project more than 55,000 pregnancies were registered at 12
university-affiliated medical centres between 1958 and 1965.
We identified 20 black women who registered in the
Project prior to week 12 (measured from the first day of the
last menstrual period) of their first pregnancies and who had
sera available that had been collected at the time of
registration. Each woman's pregnancy proceeded without
complication; no woman experienced hyperemesis or
toxemia; and all offspring were followed for 7 years with no
malformations noted. White women were selected to satisfy
the same criteria and each was individually matched to a
black woman by medical centre, age (within 1 year), weight
(within 4.5kg) and length of gestation (within 12 days).
Serum samples were stored in a central repository in
Bethesda, MD, at -20°C in replicate 4ml aliquots to
prevent unnecessary thawing. The samples of black women
were stored, on average, 22 years (standard deviation,
s.d.= 1.9 years) and those of white women were stored, on
average, 21.8 years (s.d. = 1.8 years). These samples were
shipped on dry ice to Endocrine Sciences Laboratory,
Tarzana, CA for measurement of E2, sex hormone binding
globulin binding capacity (SHBG-bc), testosterone and hCG
and to HLJ for measurement of percentage of free (i.e., non-
protein bound) E2. E2 was measured by the method of Wu
and Lundy (1971); the percentage of free E2 was determined
by the equilibrium dialysis method of Pardridge and Mietus
(1979); SHBG-bc was measured by the selective ammonium
sulfate precipitation technique described in Nankin et al.
(1975) using a tritiated dihydrotestosterone reference;
testosterone was measured by radioimmunoassay as
described by Furuyama et al. (1970); and hCG was
measured by a radioimmunoassay which specifically
measures hCG in the presence of human luteinizing hormone
(Vaitukaitis et al., 1972). The identity of specimens was not
known to the processing laboratories. The only identifier was
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a coded number unique for each submission of a specimen.
Because samples were collected over a 6 year time frame, we
plotted hormone values against the data of sample collection
and found no evidence of degradation with increased storage
time.
The amount of free E2 was computed as the product of
total E2 and the percentage of free E2' Hormone and
SHBG-bc values followed a lognormal distribution and
logarithmic (base 10) values of these variables were used in
all statistical analyses. Statistical analyses were performed
using the paired t-test, analysis of variance and repeated
measures analysis of covariance to adjust for differences in
length of gestation, assuming a linear relationship between
length of gestation and log hormone measures.
Black and white women were closely matched on age,
weight and length of gestation (Table I). Subjects ranged in
age from 17 to 26 years. At the start of their pregnancies,
subjects ranged in weight from 43 to 79.5kg. Length of
gestation at the time of sample collection ranged from 48 to
80 days since the first day of the last menstrual period.
There were no significant differences in length of pregnancy
at birth or in the birth weight of offspring.
Black women had testosterone levels that were 48% higher
than those of white women during the early weeks of
gestation (2-sided, P=0.0009). Black women had total E2
levels that were 37% higher, free E2 levels that were 30%
higher and SHBG-bc levels that were 22% higher than those
of white women, but none of these results was statistically
significant. There were no differences in the level of hCG or
the percentage of free E2. Adjustment of these comparisons
for length of gestation did not alter the findings. Twelve
white women and 11 black women had male offspring, and
adjustment for sex of the offspring had no effect on the
results presented.
Table I Relevant pregnancy characteristics (±s.d.) of study subjects
and geometric mean hormone levels (with 95% confidence limits) for
20 white and 20 black women registered for their first pregnancies in
the Collaborative Perinatal Project. For statistical analyses, paired t-
tests were used and 2-sided P values are presented
Variable Mite women Black women P value
Relevant pregnancy characteristics (±s.d.)
Age (yr) 20.6 (±2.5) 20.6 (±2.5) 1.00
Weight (kg) 56.9 (±7.4) 57.3 (±7.6) 0.37
Days of gestation
at sampling 66.3 (±9.2) 67.4 (±8.3) 0.27
Weeks of gestation
at birth 40.3 (± 1.2) 39.6 (± 1.7) 0.10
Birth weight of
offspring (g) 3331 (± 353) 3135 (±617) 0.23
Geometric mean hormone levels (95% confidence limits)
Testosterone
(ngddl) 77.3 (65.3, 91.4) 114.4 (97.3, 134.3) 0.0009
E2
Total (pgdl-') 138.4 (106.6, 179.5) 189.4 (136.3, 262.7) 0.09
Free (pgdl-') 1.28 (1.06, 1.54) 1.66 (1.25, 2.20) 0.10
Percent freea 0.96 (0.84, 1.08) 0.90 (0.79, 1.01) 0.42
SHBG-bc (ugddl) 4.65 (3.60, 5.99) 5.69 (4.11, 7.86) 0.25
hCG (IUml-1) 37.5 (28.8, 48.8) 37.4 (23.8, 58.9) 0.99
aArithmetic mean.
These findings suggest the possibility that not only E2
levels, but also the amount of testosterone in the circulating
maternal blood, are important factors in the development of
the testis. Testosterone is necessary for the virilization of the
male urogenital tract (Wilson et al., 1981). High maternal
testosterone levels such as those observed in black women in
this study may ensure this orderly process by crossing the
placenta into the foetal circulation. There is evidence that
exogenous and endogenous maternal testosterone levels
affect foetal genitourinary development. Women treated with
certain oral progestins (testosterone analogs) during
pregnancy have delivered female offspring with congenital
masculinization of the external genitalia suggesting that these
steroids have a direct androgenic action on the foetus
(Grumbach et al., 1959). The virilizing effects on female
foetuses of high levels of endogenous testosterone which
were caused by a variety of pregnancy associated ovarian
tumours including luteomas and mucinous cystadenomas
have been described (Malinak & Miller, 1965; Jenkins et al.,
1968; Verhoeven et al., 1973). Thus, the excess of testo-
sterone in the early gestational blood of black women
provides a possible explanation for the subsequent lower
incidence of testis cancer in black male offspring as it may
counteract the effects of elevated oestrogen.
We note that the incidence of cryptorchidism in black
males is only one-third that of white males (Heinonen et al.,
1977). In rats, oestrogen-inhibited testicular descent can be
reversed by treatment with androgens (Rajfer & Walsh,
1977). Furthermore, defects of male sexual differentiation,
such as androgen insensitivity (testicular feminisation)
syndrome, and gonadal dysgenesis are associated with
defects of testosterone action or biosynthesis and males with
these conditions show a predisposition to germ cell tumours
of the testis (Mishell, 1979; Muller & Skakkebaek, 1984).
We have previously reported that young adult black males
have higher levels of circulating testosterone than their white
counterparts (Ross et al., 1986). In this paper, we showed
that this excess is sufficient to 'explain' the two-fold
increased lifetime risk of prostate cancer in blacks compared
to whites using a model of 'prostate tissue aging' based on
the exponential relationship of cancer risk to exposure time
(Pike et al., 1983). It seems reasonable to conjecture that the
relative excess of testosterone in early gestational black
women predisposes their male offspring to this constitutional
development. Unresolved are the reasons for the testosterone
excess. As prostate cancer risk and testosterone levels are
lower in blacks in West Africa than in U.S. blacks (Ahluwalia
et al., 1981), a simple genetic predisposition does not seem
to be an appropriate explanation. Malnutrition results in
lowered postpubertal testosterone levels in mice (Jean-
Faucher et al., 1982) and a reduction in fat intake has been
reported to reduce circulating testosterone levels in man (Hill
& Wynder, 1979). Thus, a combination of environmental
factors such as diet and even specific nutrients, e.g., fat, may
be relevant and are worthy of investigation.
In summary, the relative amounts of maternal oestrogen
and testosterone, circulating during early gestation when the
testis is developing, may play a role in subsequent disease
outcomes in male offspring.
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